Conrad Lichtenstein
Fondatore presso Nemesis Biosciences Ltd.
Profilo
Conrad Lichtenstein is the founder of Nemesis Biosciences Ltd.
which was founded in 2014, where he holds the title of Chief Scientific Officer.
He also worked as Chief Scientific Officer at Population Genetics Technologies Ltd.
Posizioni attive di Conrad Lichtenstein
| Società | Posizione | Inizio |
|---|---|---|
Nemesis Biosciences Ltd.
 Nemesis Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Nemesis Biosciences Ltd. develops and commercializes therapeutic agents that resurrect the antibiotic sensitivity of currently resistant microbial pathogens. Its symbiotics kill pathogenic microorganisms directly and/or make them susceptible to currently existing antibiotics. The company was founded by Frank Massam, Conrad Lichtenstein and Gi Mikawa in March 2014 and is headquartered in Cambridge, the United Kingdom. | Fondatore | 01/03/2014 |
Precedenti posizioni note di Conrad Lichtenstein
| Società | Posizione | Fine |
|---|---|---|
Population Genetics Technologies Ltd.
 Population Genetics Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Population Genetics Technologies Ltd. offers population genetics. The firm develops and patents technologies that find, characterize and quantify true genetic variants responsible for disease, disease resistance and drug response for agricultural biotechnology, infectious disease and cancer markets. The company was founded by Sydney Brenner, Sam Eletr, Philip Goelet and Nobel Laureate on April 30, 2004 and is headquartered in Cambridge, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Population Genetics Technologies Ltd.
Population Genetics Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Population Genetics Technologies Ltd. offers population genetics. The firm develops and patents technologies that find, characterize and quantify true genetic variants responsible for disease, disease resistance and drug response for agricultural biotechnology, infectious disease and cancer markets. The company was founded by Sydney Brenner, Sam Eletr, Philip Goelet and Nobel Laureate on April 30, 2004 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Nemesis Biosciences Ltd.
Nemesis Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Nemesis Biosciences Ltd. develops and commercializes therapeutic agents that resurrect the antibiotic sensitivity of currently resistant microbial pathogens. Its symbiotics kill pathogenic microorganisms directly and/or make them susceptible to currently existing antibiotics. The company was founded by Frank Massam, Conrad Lichtenstein and Gi Mikawa in March 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Conrad Lichtenstein
